A Drug Interaction Study With Albiglutide and Warfarin

Clinical trial NCT01147731 · COMPLETED

Trial details

NCT number: NCT01147731
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-06-04
Primary completion: 2010-09-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.